Daiichi Sankyo
Roshni Shah currently serves as the Director of Global Regulatory Affairs at Daiichi Sankyo US since April 2024. Prior to this role, Roshni held the position of Director, Global Regulatory Strategist at Bayer from July 2021 to March 2024. Roshni's expertise in regulatory affairs was further honed at Roche, where Roshni worked as an Associate Regulatory Program Director and Regulatory Program Manager from May 2014 to July 2021. Additionally, Roshni gained valuable experience as a Rutgers Post-Doctoral Fellow in both Regulatory Affairs and Regulatory Policy and Intelligence at Genentech from October 2012 to May 2014 and at Roche Pharmaceuticals for a brief period in 2012. Roshni's early career included an internship as a Pharmacy Intern at CVS Caremark Corporation from June 2007 to July 2011. Roshni holds a Doctor of Pharmacy (PharmD) degree from Rutgers University–New Brunswick.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.